𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis of 3H-labelled levamisole

✍ Scribed by J. J. A. Thijssen; A. A. Knaeps; W. W. M. Verluyten; J. J. P. Heykants; C. C. M. Janssen


Publisher
John Wiley and Sons
Year
1987
Tongue
French
Weight
314 KB
Volume
24
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Synthesis of 3H-labelled flupamesone
✍ V. Rimbau; J. Forn πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 French βš– 140 KB
Synthesis of 14C-labeled levamisole and
✍ V. J. Feil πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 275 KB πŸ‘ 2 views

The syntheses of '%-ring labeled levamisole ([-)-2,3,5,6-tetrahydr0-6-phenyl[~'C-UL]imidazo(Z, 1b]thiole) from acetophenone-ring-UL-l'C in 5 steps plus resolution with a 7.5% overall yield, and %,-ring labeled tetramisole ([i]-2,3,5,6-tetrahydro-6-phenyif3 S ]imidaz0[2,?-bjthiazole) from benzene-'%,

Synthesis of 3h-labelled enalapril malea
✍ J. Bartroli; J. Ramis; A. Marin; J. Forn πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 French βš– 262 KB

The 4gnth-i~ o{ e n d a p d d e a t e (RK 4211 La- beUed w i t h t/tltiwn at ih p o L i n e iuhg u d ~a i b e d . ih, M e f f ' -~~o x p u c c m m u + l wten o t a N-cwtboxyaLh# & m i n e d d v a t i v e IUM aeac-Led w i t h L-[4,5-H J p o 4 i n e and M e urude neac- .tion mixtcute fneaked w i t h d

Synthesis of deuterium and tritium label
✍ Nicholas C. Sangster; Ernest Lacey; Chit Than; Mervyn A. Long πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 349 KB

Levamisole (LEV) i s a w i d e l y used a n t i -p a r a s i t i c agent. I n o r d e r t o c h a r a c t e r i s e t h e biochemical pharmacology o f LEV i n p a r a s i t i c nematodes, [3H]LEV and a more a c t i v e analogue [3H]m-aminolevamisole (MAL) have been prepared. Label1 i n g was accompl

Synthesis of 3H-labelled indicine N-oxid
✍ James R. Piper; Prasad Kari; Y. Fulmer Shealy πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 French βš– 474 KB

## Abstract Indicine __N__‐oxide, an antitumor agent possessing an unusual type of potential alkylating capacity, was recently selected for clinical trial. Radioactive‐labelled indicine __N__‐oxide was sought for studies of its biological properties relating to antitumor activity and toxicity. Avai